Angelica sinensis down-regulates hydroxyproline and Tgfb1 and provides protection in mice with radiation-induced pulmonary fibrosis

Radiation Research

Volumn 165, Issue 5, 2006, Pages 546-552

  Han, Guang ^a   Zhou, Yun Feng ^a   Zhang, Ming Sheng ^a   Cao, Zhen ^a   Xie, Cong Hua ^a   Zhou, Fu Xiang ^a   Peng, Min ^a   Zhang, Wen Jie ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGELICA SINENSIS EXTRACT; CHEMOATTRACTANT; HYDROXYPROLINE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FEMALE; FIBROBLAST; LUNG FIBROSIS; LUNG PARENCHYMA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIATION INJURY; RADIATION PROTECTION; RELIABILITY; X IRRADIATION;

ANIMALS; DOWN-REGULATION; DRUGS, CHINESE HERBAL; FEMALE; HYDROXYPROLINE; LUNG; MICE; MICE, INBRED C57BL; RADIATION PNEUMONITIS; RADIATION-PROTECTIVE AGENTS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TREATMENT OUTCOME;

ANGELICA SINENSIS; ANIMALIA;

EID: 33646464082     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3543.1     Document Type: Article

References (40)

1. F. Morgan, B. Pharm and S. N. Breit, Radiation and the lung: A reevaluation of the mechanisms mediating pulmonary injury. Int. J. Radiat. Oncol. Biol. Phys. 31, 361-369 (1995).
2. B. Movsas, T. A. Raffin, A. H. Epstein and C. J. Link, Pulmonary radiation injury. Chest 111, 1061-1076 (1997).
3. J. D. Cox, N. Azarnia, R. W. Byhardt, K. H. Shin, B. Emami and T. F. Pajak, A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11. J. Clin. Oncol. 8, 1543-1555 (1990).
4. B. Jeremic, Y. Shibamoto, L. Acimovic and L. Djuric, Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. J. Clin. Oncol. 13, 452-458 (1995).
5. M. Murakami, Y. Kuroda, T. Nakajima, Y. Okamoto, T. Mizowaki and F. Kusumi. Comparison between chemoradiation protocol intended for organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 45, 277-284 (1999).
6. C. M. Roberts, E. Foulcher, J. J. Zaunders, D. H. Bryant, J. Freund, D. Cairns, R. Penny, G. W. Morgan and S. N. Breit, Radiation pneumonitis: A possible lymphocyte-mediated hypersensitivity reaction. Ann. Intern. Med. 118, 696-700 (1993).
7. J. D. Ritzenthaler, R. H. Goldstein, A. Fine and B. D. Smith, Regulation of the alpha 1 (I) collagen promoter via a transforming growth factor-beta activation element. J. Biol. Chem. 268, 13625-13631 (1993).
8. A. B. Roberts, M. B. Sporn, R. K. Assoian, J. M. Smith, N. S. Roche and L. M. Wakefield, Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83, 4167-4171 (1986).
9. H. P. Rodemann and M. Bamberg, Cellular basis of radiation-induced fibrosis. Radiother. Oncol. 35, 83-90 (1995).
10. H. P. Rodemann, A. Binder, A. Burger, N. Güven, H. Löffler and M. Bamberg, The underlying cellular mechanism of fibrosis. Kidney Int. 49, S32-S36 (1996).
11. A. Magnan, I. Frachon, B. Rain, M. Peuchmaur, G. Monti, B. Lenot, M. Fattal, G. Simonneau, P. Galanaud and D. Emilie, Transforming growth factor β in normal human lung: Preferential location in bronchial epithelial cells. Thorax 49, 789-792 (1994).
12. T. Masui, L. M. Wakefield, J. F. Lechner, M. A. LaVeck, M. B. Sporn and C. C. Harris, Type β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc. Natl. Acad. Sci. USA 83, 2438-2442 (1986).
13. T. J. Broekelmann, A. H. Limper, T. V. Colby and J. A. McDonald, Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 88, 6642-6646 (1991).
14. K. Zhang, K. C. Flanders and S. H. Phan, Cellular localization of transforming growth factor-β expression in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 147, 352-361 (1995).
15. M. S. Anscher, I. R. Crocker and R. L. Jirtle, Transforming growth factor-β1 expression in irradiated liver. Radiat. Res. 122, 77-85 (1990).
16. P. J. Sime, Z. Xing, F. L. Graham, K. G. Csaky and J. Gauldie, Adenovirus-mediated gene transfer of active transforming growth factor-β1 induces prolonged severe fibrosis in rat lungs. J. Clin. Invest. 100, 768-776 (1997).
17. P. Rubin, J. N. Finkelstein and D. Shapiro, Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: Interrelationship between the alveolar macrophage and the septal fibroblast. Int. J. Radiat. Oncol. Biol. Phys. 24, 93-101 (1992).
18. P. Rubin, C. J. Johnston, J. P. Williams, S. McDonald and J. N. Finkelstein, A perpetual cascade of cytokines post irradiation leads to pulmonary fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 33, 99-109 (1995).
19. M. S. Anscher, F. M. Kong, K. Andrews, R. Clough, L. B. Marks, G. Bentel and R. L. Jirtle, Plasma transforming growth factor β1 as a predictor of radiation pneumonitis. Int. J. Radiat. Oncol. Biol. Phys. 41, 1029-1035 (1998).
20. D. J. Prockop and S. A. Udenfriend, Specific method for the analysis of hydroxyproline in tissues and urine. Anal. Biochem. 1, 228-239 (1960).
21. J. M. Seyer, E. T. Hutcheson and A. H. Kang, Collagen polymorphism in idiopathic chronic pulmonary fibrosis. J. Clin. Invest. 57, 1498-1507 (1976).
22. J. P. Kehrer, Y. C. Lee and S. M. Solem, Comparison of in vitro and in vivo rates of collagen synthesis in normal and damaged lung tissue. Exp. Lung. Res. 10, 197-201 (1986).
23. H. Yamada, H. Kiyohara, J. C. Cyong, Y. Kojima, Y. Kumazawa and Y. Otsuka, Studies on polysaccharides from Angelica acutiloba. Planta. Med. 50, 163-167 (1984).
24. S. H. Kim, S. E. Lee, H. Oh, S. R. Kim, S. T. Yee, Y. B. Yu, M. W. Byun and S. K. Jo, The radioprotective effects of Bu-Zhong-Yi-Qi-Tang: A prescription of traditional Chinese medicine. Am. J. Chin. Med. 30, 127-137 (2002).
25. X. Wang, L. Wei, J. P. Ouyang, S. Muller, M. Gentils, G. Cauchois and J. F. Stoltz, Effects of an angelica extract on human erythrocyte aggregation, deformation and osmotic fragility. Clin. Hemorheol. Microcirc. 24, 201-205 (2001).
26. F. Xie, X. Li, K. Sun, Y. Chu, H. Cao, N. Chen, W. Wang, M. Liu, W. Liu and D. Mao, An experimental study on drugs for improving blood circulation and removing blood stasis in treating mild chronic hepatic damage. J. Tradit. Chin. Med. 21, 225-231 (2001).
27. H. B. Cai and R. C. Luo, Prevention and therapy of radiation-induced pulmonary injury with traditional Chinese medicine. J. First Mil. Med. Univ. 23, 958-960 (2003).
28. C. E. Rube, F. Wilfert, D. Uthe, K. W. Schmid, R. Knoop, N. Willich, A. Schuck and C. Rube, Modulation of radiation induced tumour necrosis factor a (TNF-α) expression in the lung tissue by pentoxifylline. Radiother. Oncol. 64, 177-187 (2002).
29. M. Lange and M. Malyusz, Improved determination of small amounts of free hydroxyproline in biological fluids. Clin. Chem. 40, 1735-1738 (1994).
30. C. A. Heid, J. Stevens, K. J. Livak and P. M. Williams, Real time quantitative PCR. Genome Res. 6, 986-994 (1996).
31. L. Overbergh, D. Valckx, M. Waer and C. Mathieu, Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11, 305-312 (1999).
32. A. Pines, N. Kaplinsky, D. Olchovsky, J. Rozenman and O. Frankl, Pleuro-pulmonary manifestations of systemic lupus erythematosus: Clinical features of its subgroups. Chest 88, 129-135 (1985).
33. E. S. Yi, A. Bedoya, H. Lee, E. Chin, W. Saunders, S. J. Kim, D. Danielpour, D. G. Remick, S. Yin and T. R. Ulich, Radiation-induced lung injury in vivo: expression of transforming growth factor-β precedes fibrosis. Inflammation 20, 339-352 (1996).
34. K. R. Trott, T. Herrmann and M. Kasper, Target cells in radiation pneumopathy. Int. J. Radiat. Oncol. Biol. Phys. 58, 463-469 (2004).
35. C. X. Yao, Clinical analysis on shengmai injection in treating radiation pneumonia and pulmonary fibrosis. Chin. J. Radiol. Med. Prot. 24, 52-53 (2004).
36. M. T. Hsieh, Y. T. Lin, Y. H. Lin and C. R. Wu, Radix angelica sinensis extracts ameliorate scopolamine and cycloheximide induced amnesia, but not p-chloroamphetamine-induced amnesia in rats. Am. J. Chin. Med. 28, 263-272 (2000).
37. C. H. Xie, Y. F. Zhou, G. Peng, H. Liu, J. Chen and T. M. Xian, Modulation by Angelica sinensis the expression of tumor necrosis factor α in radiation-induced damage of the lung. Chin. J. Radiat. Oncol. 14, 59-63 (2005).
38. X. H. Lu, J. J. Zhang, H. Liang and Y. Y. Zhao, Chemical Constituents of Angelica sinensis. J. Chin. Pharm. Sci. 13, 1-3 (2004).
39. B. H. Wang, J. P. Ou, Yang, L. Wei, Y. M. Liu, H. Q. Zheng and S. Z. Tu, Modulation role of Angelica sinensis and ferulic acid on expression of cytokine in endothelial cell. Chin. J. Pathophys. 16, 982 (2000).
40. W. H. Huang and C. Q. Song, Progress in research of Angelica sinensis's chemistry and pharmacology. China J. Chin. Mater. Med. 26, 147-155 (2001).